Replacement of human anterior cruciate ligaments with pig ligaments

A model for anti-non-gal antibody response in long-term xenotransplantation

Kevin R. Stone, Ussama M. Abdel-Motal, Ann W. Walgenbach, Thomas J. Turek, Uri Galili

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

BACKGROUND. Understanding anti-non-gal antibody response is of significance for success in xenotransplantation. Long-term anti-non-gal response in humans was studied in patients transplanted with porcine patellar tendon (PT) lacking α-gal epitopes, for replacing ruptured anterior cruciate ligament (ACL). METHODS. Porcine PTs were treated with recombinant α-galactosidase to eliminate α-gal epitopes and with glutaraldehyde for moderate cross-linking of collagen fibers. The processed pig PTs were implanted to replace ruptured ACL in patients. RESULTS. In five of six evaluable subjects, the xenografts have continued to function for over two years and passed all functional stability assessments. Thus, processed porcine PT seems to be appropriate for replacing ruptured human ACL. Enzyme-linked immunosorbent assay and Western blot studies indicated that all subjects produced anti-non-gal antibodies against multiple pig xenoproteins, but not against human ligament proteins. Production of anti-non-gal antibodies peaked two to six months posttransplantation and disappeared after two years. CONCLUSIONS. These antibodies contribute to a low-level inflammatory process that aids in gradual xenograft replacement by infiltrating host fibroblasts that align with the pig collagen "scaffold" and secrete collagen matrix. The assays monitoring anti-non-gal antibodies will help to determine whether long-term survival of live organ xenografts requires complete suppression of this antibody response.

Original languageEnglish
Pages (from-to)211-219
Number of pages9
JournalTransplantation
Volume83
Issue number2
DOIs
Publication statusPublished - Jan 2007
Externally publishedYes

Fingerprint

Heterologous Transplantation
Anterior Cruciate Ligament
Ligaments
Antibody Formation
Swine
Heterografts
Patellar Ligament
Collagen
Antibodies
Epitopes
Galactosidases
Tissue Survival
Glutaral
Fibroblasts
Western Blotting
Enzyme-Linked Immunosorbent Assay
Proteins

Keywords

  • α-Galactosidase
  • Anterior cruciate ligament
  • Anti-gal antibodies
  • Anti-non-gal antibodies
  • Pig-to-human xenotransplantation

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Replacement of human anterior cruciate ligaments with pig ligaments : A model for anti-non-gal antibody response in long-term xenotransplantation. / Stone, Kevin R.; Abdel-Motal, Ussama M.; Walgenbach, Ann W.; Turek, Thomas J.; Galili, Uri.

In: Transplantation, Vol. 83, No. 2, 01.2007, p. 211-219.

Research output: Contribution to journalArticle

@article{3479f0f955924213ad98b6347d1c451b,
title = "Replacement of human anterior cruciate ligaments with pig ligaments: A model for anti-non-gal antibody response in long-term xenotransplantation",
abstract = "BACKGROUND. Understanding anti-non-gal antibody response is of significance for success in xenotransplantation. Long-term anti-non-gal response in humans was studied in patients transplanted with porcine patellar tendon (PT) lacking α-gal epitopes, for replacing ruptured anterior cruciate ligament (ACL). METHODS. Porcine PTs were treated with recombinant α-galactosidase to eliminate α-gal epitopes and with glutaraldehyde for moderate cross-linking of collagen fibers. The processed pig PTs were implanted to replace ruptured ACL in patients. RESULTS. In five of six evaluable subjects, the xenografts have continued to function for over two years and passed all functional stability assessments. Thus, processed porcine PT seems to be appropriate for replacing ruptured human ACL. Enzyme-linked immunosorbent assay and Western blot studies indicated that all subjects produced anti-non-gal antibodies against multiple pig xenoproteins, but not against human ligament proteins. Production of anti-non-gal antibodies peaked two to six months posttransplantation and disappeared after two years. CONCLUSIONS. These antibodies contribute to a low-level inflammatory process that aids in gradual xenograft replacement by infiltrating host fibroblasts that align with the pig collagen {"}scaffold{"} and secrete collagen matrix. The assays monitoring anti-non-gal antibodies will help to determine whether long-term survival of live organ xenografts requires complete suppression of this antibody response.",
keywords = "α-Galactosidase, Anterior cruciate ligament, Anti-gal antibodies, Anti-non-gal antibodies, Pig-to-human xenotransplantation",
author = "Stone, {Kevin R.} and Abdel-Motal, {Ussama M.} and Walgenbach, {Ann W.} and Turek, {Thomas J.} and Uri Galili",
year = "2007",
month = "1",
doi = "10.1097/01.tp.0000250598.29377.13",
language = "English",
volume = "83",
pages = "211--219",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Replacement of human anterior cruciate ligaments with pig ligaments

T2 - A model for anti-non-gal antibody response in long-term xenotransplantation

AU - Stone, Kevin R.

AU - Abdel-Motal, Ussama M.

AU - Walgenbach, Ann W.

AU - Turek, Thomas J.

AU - Galili, Uri

PY - 2007/1

Y1 - 2007/1

N2 - BACKGROUND. Understanding anti-non-gal antibody response is of significance for success in xenotransplantation. Long-term anti-non-gal response in humans was studied in patients transplanted with porcine patellar tendon (PT) lacking α-gal epitopes, for replacing ruptured anterior cruciate ligament (ACL). METHODS. Porcine PTs were treated with recombinant α-galactosidase to eliminate α-gal epitopes and with glutaraldehyde for moderate cross-linking of collagen fibers. The processed pig PTs were implanted to replace ruptured ACL in patients. RESULTS. In five of six evaluable subjects, the xenografts have continued to function for over two years and passed all functional stability assessments. Thus, processed porcine PT seems to be appropriate for replacing ruptured human ACL. Enzyme-linked immunosorbent assay and Western blot studies indicated that all subjects produced anti-non-gal antibodies against multiple pig xenoproteins, but not against human ligament proteins. Production of anti-non-gal antibodies peaked two to six months posttransplantation and disappeared after two years. CONCLUSIONS. These antibodies contribute to a low-level inflammatory process that aids in gradual xenograft replacement by infiltrating host fibroblasts that align with the pig collagen "scaffold" and secrete collagen matrix. The assays monitoring anti-non-gal antibodies will help to determine whether long-term survival of live organ xenografts requires complete suppression of this antibody response.

AB - BACKGROUND. Understanding anti-non-gal antibody response is of significance for success in xenotransplantation. Long-term anti-non-gal response in humans was studied in patients transplanted with porcine patellar tendon (PT) lacking α-gal epitopes, for replacing ruptured anterior cruciate ligament (ACL). METHODS. Porcine PTs were treated with recombinant α-galactosidase to eliminate α-gal epitopes and with glutaraldehyde for moderate cross-linking of collagen fibers. The processed pig PTs were implanted to replace ruptured ACL in patients. RESULTS. In five of six evaluable subjects, the xenografts have continued to function for over two years and passed all functional stability assessments. Thus, processed porcine PT seems to be appropriate for replacing ruptured human ACL. Enzyme-linked immunosorbent assay and Western blot studies indicated that all subjects produced anti-non-gal antibodies against multiple pig xenoproteins, but not against human ligament proteins. Production of anti-non-gal antibodies peaked two to six months posttransplantation and disappeared after two years. CONCLUSIONS. These antibodies contribute to a low-level inflammatory process that aids in gradual xenograft replacement by infiltrating host fibroblasts that align with the pig collagen "scaffold" and secrete collagen matrix. The assays monitoring anti-non-gal antibodies will help to determine whether long-term survival of live organ xenografts requires complete suppression of this antibody response.

KW - α-Galactosidase

KW - Anterior cruciate ligament

KW - Anti-gal antibodies

KW - Anti-non-gal antibodies

KW - Pig-to-human xenotransplantation

UR - http://www.scopus.com/inward/record.url?scp=33846620083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846620083&partnerID=8YFLogxK

U2 - 10.1097/01.tp.0000250598.29377.13

DO - 10.1097/01.tp.0000250598.29377.13

M3 - Article

VL - 83

SP - 211

EP - 219

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 2

ER -